National Aeronautics and Space Administration March 2, 2010 – Federal Register Recent Federal Regulation Documents

This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive, license in the United States to practice the invention described and claimed in US Patent Application No. 10/ 885,537, and NASA Case No. ARC-15204-1 entitled ``Rapid Polymer Sequencer'' to Abraxis BioScience, LLC, having its principal place of business in 11755 Wilshire Blvd. Suite 2000, Los Angeles, CA 90025. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.